Daily brief

Tower beats forecasts and raises its outlook; Perion agrees a $420M sale to Affle; Israel Railways plans a direct line to the airport

Israel's earnings season opens strongly: Tower's Q3 revenue is up 33% to $526M, and Perion shares jump about 30% on the Affle deal.

Today in Israel - and what it all means for the business community at home and abroad.

TV10 Global Editorial · Monday, November

Want to join the conversation? We’re on X 2, 2026

Quick takes

  • Tower: Q3 revenue $526M, up 33% from $396M and above consensus; net profit 2.2x to $120M (TV10).

  • Perion: agreed to merge with India’s Affle at $11.70 cash a share, about $420M, a 34.5% premium to Friday’s close; shares up about 30% in Tel Aviv (TV10).

  • TAT Technologies: Q3 revenue $55.6M, up 20.2%; net profit up 58.6% to $7.7M (TV10).

  • Rail: new timetable from Saturday night, 14 November, with a direct Sharon-airport-Jerusalem service (Israel Railways, via TV10).

Earnings: the season opens with Tower

Tower Semiconductor reported record third-quarter revenue of $526M, up 33% from $396M a year earlier and above analysts’ consensus. Net profit more than doubled to $120M. It guides to record fourth-quarter revenue of about $600M, on the way to roughly $2B for the year, and TV10 names silicon photonics as the main growth engine. TAT Technologies, the aviation and defense supplier, grew revenue 20.2% to $55.6M, with net profit up 58.6% to $7.7M and operating profit up 71.8% to $9M. Gav-Yam opened the local season with net profit up 68%.

Original (Hebrew): https://tv10.co.il/126629/ · https://tv10.co.il/126630/ · https://tv10.co.il/126623/

Our take: A strong start for the local season after a red October, led by an exporter. The guidance matters more than the quarter.

Deals: Perion sold to Affle

Perion agreed a binding merger with India’s advertising-technology company Affle. Shareholders receive $11.70 in cash a share, a company value of about $420M and a 34.5% premium to Friday’s close. The stock, listed in Tel Aviv and on Nasdaq, rose about 30% on Monday. Gene Technologies rose about 7% on reports of talks on a government deal abroad worth up to $5M a year. The leading indexes traded steadily at midday.

Original (Hebrew): https://tv10.co.il/126623/ · https://tv10.co.il/126618/

Our take: A cash premium deal for a dual-listed Israeli firm; the shares now trade on closing risk rather than growth.

Defense and transport

Rafael said its SPIKE missile systems have been sold to 48 countries, at the SPIKE user club’s 21st annual meeting in Cyprus, where a new loitering munition for existing launchers was shown (TV10). Israel Railways will launch a new timetable on Saturday night, 14 November, after a record 72M trips in 2025 and over 300K a day in the first half of 2026. It adds a direct service from the Sharon (Hadera, Netanya) to Ben Gurion Airport and Jerusalem, with about 140K more seats; feeder lines are shortened and the trip to Haifa gets longer.

Original (Hebrew): https://tv10.co.il/126628/ · https://tv10.co.il/126627/

Our take: Export demand for Israeli defense products and rising rail use both point to steady real-economy demand.

Watch list

  • Tue 3 Nov: Teva reports.

  • Wed 4 Nov: Camtek reports; official election results are due.

  • Thu 5 Nov: Nova and El Al report; the petrol maximum price changes depending on the final excise order.

For information only. Not investment advice. Sources are cited in each section; figures are as reported at the time of writing.